Biomarker Services

High-performance (multi-array) ligand-binding assays

In vitro and in vivo studies: one sample – multiple readouts

Pharmacelsus supports the entire process of preclinical drug development: pharmacokinetics, pharmacodynamics, toxicology, in order to predict the risk of harmful reactions and help you to choose the most suitable candidate for clinical trials.

Using leading-edge multi-array technologies we offer multiplex high-throughput detection, quantification and characterization of Biomarkers (cytokines, hormones, enzymes) and Biopharmaceuticals (e.g. monoclonal antibodies) in different biological matrices from pre-clinical (non-GLP/GLP) as well as clinical studies (GCLP).

These technologies require only small sample volumes and allow multiplex tests on a single sample with high sensitivity and reliability.

Your contact at Pharmacelsus

MUDr. Maria Li
Director Business Development

Mobile: +49 173 889 4288

Mail: m.li@gba-pharma.com

Pharmacokinetic / Toxicokinetic

Safety and Efficacy Determination
Liver and Kidney-tox

Biomarker Analysis

Metabolic
Immune
Cancer
Neuroscience
Allergic reaction

Immunogenicity Testing

Screening Assay

Immuneresponse

Innate
Adaptive
Anti-drug Antibodies

Matrixes

Ability to analyze a wide range of sample types e.g. cell culture supernatant, cell lysates/tissue homogenates, serum/plasma, whole Blood, sputum, urine, CSF, tumor extracts, tears, etc.